paclitaxel has been researched along with Lacrimal Duct Obstruction in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmadi, MA; Esmaeli, B; Hutto, T; Jackson, DM; Newman, RA; Rivera, E; Valero, V | 1 |
Doughman, DJ; Skolnick, CA | 1 |
Ahmadi, MA; Burnstine, MA; Esmaeli, B; Prieto, VG | 1 |
Adinin, RB; Ahmadi, MA; Arbuckle, R; Coats, C; Esmaeli, B; Faustina, M; Hidaji, L; Rivera, E; Tu, SM; Valero, V | 1 |
Ahmadi, MA; Booser, D; Esmaeli, B; Valero, V | 1 |
Ahmadi, MA; Esmaeli, B | 1 |
Esmaeli, B; Hortobagyi, GN | 1 |
Ahmadi, MA; Arbuckle, R; Booser, D; Delpassand, E; Esmaeli, B; Esteva, F; Hortobagyi, G; Ibrahim, N; Valero, V | 1 |
Ahmadi, MA; Arbuckle, R; Booser, D; Delpassand, E; Esmaeli, B; Esteva, FJ; Guerra, L; Hortobagyi, GN; Rivera, E; Valero, V | 1 |
2 trial(s) available for paclitaxel and Lacrimal Duct Obstruction
Article | Year |
---|---|
Docetaxel secretion in tears: association with lacrimal drainage obstruction.
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chromatography, High Pressure Liquid; Docetaxel; Female; Gas Chromatography-Mass Spectrometry; Humans; Infusions, Intravenous; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Pilot Projects; Prospective Studies; Taxoids; Tears | 2002 |
Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Humans; Intubation; Lacrimal Apparatus; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Trastuzumab | 2002 |
7 other study(ies) available for paclitaxel and Lacrimal Duct Obstruction
Article | Year |
---|---|
Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere).
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Conjunctivitis; Docetaxel; Female; Humans; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids | 2003 |
Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa.
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dacryocystorhinostomy; Docetaxel; Female; Humans; Intubation; Lacrimal Apparatus; Lacrimal Duct Obstruction; Middle Aged; Nasal Mucosa; Paclitaxel; Silicone Elastomers; Taxoids | 2003 |
Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Squamous Cell; Dacryocystorhinostomy; Docetaxel; Drainage; Esophageal Neoplasms; Female; Humans; Intubation; Lacrimal Duct Obstruction; Lung Neoplasms; Male; Middle Aged; Nasolacrimal Duct; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Taxoids; Texas | 2003 |
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
Topics: Adult; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fibrosis; Humans; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids; Tears | 2001 |
Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dacryocystorhinostomy; Docetaxel; Drug Administration Schedule; Female; Glass; Humans; Infusions, Intravenous; Intubation; Lacrimal Duct Obstruction; Middle Aged; Nasolacrimal Duct; Paclitaxel; Silicone Elastomers; Taxoids; Tears | 2001 |
Canalicular stenosis as the underlying mechanism for epiphora in patients receiving weekly docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Paclitaxel | 2001 |
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids | 2002 |